UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.003

Sortiert nach

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2014-03, Vol.32 (7), p.671-677

2014

Link zum Volltext

Verfügbarkeit prüfen

Cellular rewiring in lethal prostate cancer: the architect of drug resistance

Nature reviews. Urology, 2020-05, Vol.17 (5), p.292-307

2020

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

Clinical cancer research, 2009-05, Vol.15 (9), p.3172-3176

2009

Link zum Volltext

Verfügbarkeit prüfen

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy

International journal of radiation oncology, biology, physics, 2014-08, Vol.89 (5), p.1038-1046

2014

Link zum Volltext

Verfügbarkeit prüfen

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy

Prostate cancer and prostatic diseases, 2020-06, Vol.23 (2), p.295-302

2020

Link zum Volltext

Verfügbarkeit prüfen

Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration

Journal of clinical oncology, 2002-10, Vol.20 (19), p.3972-3982

2002

Link zum Volltext

Verfügbarkeit prüfen

Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer

BJU international, 2015-07, Vol.116 (1), p.50-56

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

Journal of clinical oncology, 2008-05, Vol.26 (13), p.2147-2154

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer

Clinical cancer research, 2007-03, Vol.13 (6), p.1775-1782

2007

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer

Nanomedicine, 2013-11, Vol.9 (8), p.1124-1134

2013

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1439-1446

2005

Link zum Volltext

Verfügbarkeit prüfen

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

The lancet oncology, 2007-11, Vol.8 (11), p.994-1000

2007

Link zum Volltext

Verfügbarkeit prüfen

Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After Radical Prostatectomy

Journal of clinical oncology, 2005-03, Vol.23 (9), p.1962-1968

2005

Link zum Volltext

Verfügbarkeit prüfen

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

Clinical cancer research, 2005-05, Vol.11 (9), p.3210-3216

2005

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Journal of clinical oncology, 2014-04, Vol.32 (11), p.1143-1150

2014

Link zum Volltext

Verfügbarkeit prüfen

Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer

Clinical cancer research, 2005-10, Vol.11 (20), p.7454-7461

2005

Link zum Volltext

Verfügbarkeit prüfen

Redefining hormone resistance in prostate cancer

Therapeutic Advances in Medical Oncology, 2010-03, Vol.2 (2), p.107-123

2010

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases

Canadian journal of urology, 2022-12, Vol.29 (6), p.11399

2022

Link zum Volltext

Verfügbarkeit prüfen

High-Risk Localized Prostate Cancer: A Case for Early Chemotherapy

Journal of clinical oncology, 2005-11, Vol.23 (32), p.8186-8191

2005

Link zum Volltext

Verfügbarkeit prüfen

Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data

World journal of urology, 2023-09, Vol.41 (9), p.2351-2357

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial of Bortezomib and Prednisone for Castration Resistant Metastatic Prostate Cancer

The Journal of urology, 2007-12, Vol.178 (6), p.2378-2384

2007

Link zum Volltext

Verfügbarkeit prüfen

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

European urology, 2020-05, Vol.77 (5), p.563-572

2020

Link zum Volltext

Verfügbarkeit prüfen

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone

Cancer, 2007-08, Vol.110 (3), p.556-563

2007

Link zum Volltext

Verfügbarkeit prüfen

Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?

Oncology (Williston Park, N.Y.), 2018-12, Vol.32 (12), p.607, 630-607

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.003

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(941)
Mit Volltextzugriff
(871)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(590)
EZB Electronic Journals Library
(483)
Ovid Journals
(417)
IngentaConnect Journals
(395)
NUS Single-Journal Subscriptions
(321)
Elsevier ScienceDirect Journals Complete
(201)
IngentaConnect Journals
(175)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(123)
Wiley Online Library
(115)
Wiley Online Library
(86)
SpringerLink
(66)
Oxford University Press Journals Current
(61)
Oxford Journals 2020 Medicine
(55)
JSTOR
(55)
Nature Journals
(48)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(37)
Taylor & Francis Online
(34)
SAGE Complete
(34)
Taylor & Francis
(34)
Nexis
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Cellular rewiring in lethal prostate cancer: the architect of drug resistance

Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import

An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer

Genomic Prostate Cancer Classifier Predicts Biochemical Failure and Metastases in Patients After Postoperative Radiation Therapy

Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy

Nomogram for Overall Survival of Patients With Progressive Metastatic Prostate Cancer After Castration

Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

Phase I Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Advanced Cancer

Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer

Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

Pattern of Prostate-Specific Antigen (PSA) Failure Dictates the Probability of a Positive Bone Scan in Patients With an Increasing PSA After Radical Prostatectomy

Fluorodeoxyglucose Positron Emission Tomography as an Outcome Measure for Castrate Metastatic Prostate Cancer Treated with Antimicrotubule Chemotherapy

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Pilot Trial of Unlabeled and Indium-111–Labeled Anti–Prostate-Specific Membrane Antigen Antibody J591 for Castrate Metastatic Prostate Cancer

Redefining hormone resistance in prostate cancer

Neuroendocrine transformation of prostate adenocarcinoma with corpora cavernosa metastases

High-Risk Localized Prostate Cancer: A Case for Early Chemotherapy

Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: a retrospective analysis of TriNetX data

A Phase II Trial of Bortezomib and Prednisone for Castration Resistant Metastatic Prostate Cancer

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : Randomized phase 2 study of ixabepilone or mitoxantrone and prednisone

Counterpoint-Prostate Cancer Genomic Analysis: Routine or Research Only?

Suchergebnisse filtern